Health
Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT – News-Medical.Net
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option.
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
Moffitt Cancer Center…
-
Noosa News15 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News17 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General14 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General21 hours agoOne person dead after house fire in Melbourne’s south-east